Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Risk Factors, Incidence and Mortality Rates of Acute Kidney Injury in COVID-19 Patients Hospitalized in Intensive Care Unit

NCT07089693 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT07089693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07089693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Risk Factors, Incidence and Mortality Rates of Acute Kidney Injury in COVID-19 Patients Hospitalized in Intensive Care Unit
Lead sponsor
Ankara University
Phase
Observational
Overall status
Completed
Start date
July 1, 2022
Completion date
August 15, 2022
Enrollment
238 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, covid -19, intensive care unit (icu) admission, mortality